Synthon chooses Avacta’s Optim 1000 for high throughput formulation studies
3 April 2013 | By kdm communications limited
Pharmaceutical developers at Synthon have chosen an Optim 1000 high throughput, micro-volume protein analysis system...
List view / Grid view
News
Sun shines on Indian generics manufacturers
3 April 2013 | By GlobalData
India is becoming a key market for generic medicines...
Next-generation circulating tumor cell test demonstrates high efficiency and accuracy in new study
3 April 2013 | By Johnson & Johnson
“CELLSEARCH® the first and only FDA-cleared CTC test..."
CHOP collaborates with Pfizer’s Centers for Therapeutic Innovation to speed pediatric research & development
3 April 2013 | By Pfizer
CHOP and Pfizer are joining forces...
GW Pharmaceuticals announces new US patent allowance for delivery of its SATIVEX® formulation
3 April 2013 | By FTI Consulting
GW has obtained a patent in the US...
GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK
3 April 2013 | By GlaxoSmithKline
Marketing authorisation for quadrivalent (four-strain) influenza vaccine...
MedImmune, AstraZeneca’s biologics unit, acquires AlphaCore Pharma
3 April 2013 | By AstraZeneca
AstraZeneca announced that MedImmune has acquired AlphaCore Pharma, an Ann Arbor, Michigan-based biotechnology company...
Sunovion Europe announces new name
2 April 2013 | By Munro & Forster
Sunovion Europe has formally changed its name from Dainippon Sumitomo Pharma Europe Ltd. (DSPE)...
AbbVie’s HUMIRA approved in the European Union
2 April 2013 | By AbbVie
AbbVie announced that the European Commission has approved an extension of the EC marketing authorization for HUMIRA...
Biogen Idec completes purchase of full rights and control of TYSABRI®
2 April 2013 | By Biogen Idec
Biogen Idec has completed its purchase of Elan Corporation’s interest in TYSABRI® (natalizumab)...
Supreme Court denial of Glivec patent clarifies limited intellectual property protection and discourages future innovation in India
1 April 2013 | By Novartis
Novartis has never been granted an original patent for Glivec in India...
U.S. FDA approves INVOKANA™ (canagliflozin) for the treatment of adults with Type 2 diabetes
29 March 2013 | By Janssen Pharmaceuticals
The U.S. FDA has approved INVOKANA™...
Sanofi to invest USD 75 million in a new manufacturing facility in Vietnam
29 March 2013 | By Sanofi
“This new production and development center is the largest investment ever made by Sanofi in Vietnam..."
Undergraduate studies enter a whole new world with Tecan’s Infinite® M200 PRO
28 March 2013 | By kdm communications
Tecan’s Infinite® M200 PRO multimode microplate readers are helping McMaster Uni...
Pfizer’s BOSULIF® (bosutinib) receives conditional marketing authorization from the European Commission
28 March 2013 | By Pfizer
“I’m delighted the EC has approved BOSULIF..."
